Noxopharm receives green light for HERACLES clinical trial
Posted: 2 June 2025 BioMelbourne Network is pleased to share that one of our valued members, Noxopharm Limited (ASX:NOX), has received approval from the Human Research Ethics Committee for the HERACLES clinical trial. This approval follows a straightforward…
Cartherics to Present at the 2025 BIO International Convention
Posted: 2 June 2025 BioMelbourne Network is pleased to share that one of our valued members Cartherics Pty Ltd, will present at the upcoming 2025 BIO International Convention June 16-19 2025, in Boston Massachusetts. Catherics Chief Operating Officer,…
Head of Product Development
Posted: 29 May 2025 The Company: The client of our BioMelbourne Network member mexec, is a Melbourne-based, ASX-listed medical device company transforming nerve repair and improving patient outcomes. They have developed a unique approach to nerve replacement by…
Spotlight on how lung cell mapping can help prevent respiratory pandemics
Posted: 28 May 2025 The COVID-19 pandemic demonstrated the urgent need for better understanding of how viruses interact with our lungs. That’s the focus of the Doherty Institute’s Associate Professor Ash Haque and his team’s work: using a…
Monash-industry partnership wins international award for excellence in clinical research
Posted: 28 May 2025 A groundbreaking partnership between the Victorian Heart Institute at Monash University and NewAmsterdam Pharma has been recognised on the global stage, winning Clinical Partnership of the Year – Non-CRO at the 2025 Citeline Awards…
CSL Behring’s Victorian facility wins global pharmaceutical manufacturing award
Posted 28 May 2025 CSL Behring’s new facility in Broadmeadows, Victoria, has been named the 2025 Facility of the Year by the International Society for Pharmaceutical Engineering (ISPE), in the Pharma 4.0 category. The site has recently started…
Brandon Capital opens second funding round for its Cureator Incubator program
Posted: 26 May 2025 Brandon Capital has opened the second funding round for its Cureator Dementia and Cognitive Decline incubator program with up to $5 million for each project. The CUREator+ Dementia and Cognitive Decline incubator program is…
Better Health Made Here: Launching the Australian Medtech Manufacturing Alliance strategic vision
This article outlines the official launch of the Australian Medtech Manufacturing Alliance (AMMA)’s strategic plan, and captures the key themes of the inaugural AMMA virtual forum – procurement barriers, policy alignment, workforce capability, and sector collaboration – while…
Connection, courage and change: Inside the 2025 BioMelbourne Network Connecting Women Lunch
More than 600 people filled the Grand Ballroom of the Sofitel Melbourne on Collins for BioMelbourne Network’s highly anticipated 2025 Connecting Women Lunch – a flagship celebration of women and people identifying as women across our health technology…
Federal Grant Boosts Dementia Research at Monash University
Posted: 13th May 2025 Monash University received $953,751 from the Federal Government’s Medical Research Future Fund to study human brain cells for potential dementia treatments. This grant enabled the Monash Institute of Pharmaceutical Sciences to “light up” human…
Breakthrough in Vaccine Technology Promises Long-Lasting Protection
Posted: 13th May 2025 A significant advancement in vaccine technology has been made by WEHI scientists, potentially leading to long-lasting vaccines against viruses and enhanced cancer therapies. The study, published in the Journal of Experimental Medicine, utilized a…
Buy Local Push with ‘Pathway to Market’ Program Opening for Homegrown Medtech Makers
Posted: 9 May 2025 MEDIA RELEASE Buy Local Push with ‘Pathway to Market’ Program Opening for Homegrown Medtech Makers With a focus on local procurement, MTPConnect has launched its Pathway to Market – Medtech Capability Uplift Program…
